The Prevention of Rh Immunization

Transfusion Medicine Reviews

Volumn 2, Issue 3, 1988, Pages 129-150

  Bowman, John M ^a  

^a HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; RHESUS D ANTIBODY;

BLOOD GROUP RHESUS SYSTEM; DOSE RESPONSE; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; PASSIVE IMMUNIZATION; PREGNANCY; REVIEW; RHESUS ISOIMMUNIZATION;

DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; MALE; PREGNANCY; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN;

EID: 0024068480     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-7963(88)70039-5     Document Type: Article

References (90)

1. Erythroblastosis fetalis and its association with universal edema of the fetus, icterus gravis neonatorum and anemia of the newborn
2. Icterus gravis (erythroblastosis neonatorum, examination of etiologic considerations)
3. An agglutinable factor in human blood recognized by immune sera for rhesus blood
4. Hemolytic reactions following transfusions of blood of the homologous group, with three cases in which the same agglutinogen was responsible
5. Isoimmunization in pregnancy: Its possible bearing on the etiology of erythroblastosis fetalis
6. A review of Rh serology and presentation of a new terminology
7. The Rh genotype and Fisher's theory
8. u variant mother
9. Observations on subdivisions of the Rh antigen D
10. o(D)-positive human red cells
11. Blood group Rh-D factor in human trophoblast determined by immunofluorescent method
12. Diagnosis and treatment of anemia of the newborn caused by occult placental hemorrhage
13. Anemia from bleeding of the fetus into the mother's circulation
14. Demonstration von fetalem haemoglobin in den erythrozyten eines blutausstriches
15. Fetomaternal transplacental hemorrhage during pregnancy and after delivery
16. Increase of antibody titer following amniocentesis
17. Transplacental fetal hemorrhage after amniocentesis
18. Rh immunization and its prevention. The immune response in the mother
19. The pathogenesis and prevention of Rh immunization
20. Factors affecting maternal Rh immunization
21. Fetomaternal ABO incompatibility and erythroblastosis fetalis
22. Rh-isoimmunization during pregnancy: Antenatal prophylaxis
23. Preliminary report on a substance which inhibits anti-Rh serum
24. Plasmapheresis in severe Rh iso-immunization
25. Intense plasmapheresis in the pregnant Rh sensitized woman
26. Repeated small volume plasmapheresis in the management of hemolytic disease of the newborn
27. Promethazine-HCL as an immunosuppressant
28. The treatment of erythroblastosis with promethazine hydrochloride
29. Promethazine hydrochloride: Use in patients with Rh isoimmunization
30. Oral Rh treatment for severely immunised mothers
31. Oral desensitization in Rh disease
32. Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin
33. Beitrage zur immunitatslehr
34. Experimental studies on Rh immunization
35. Experimental iso-immunization to hemo-antigens in man
36. Further experimental studies in the prevention of Rh-haemolytic disease
37. Successful prevention of experimental Rh sensitization in man with an anti-Rh gammaglobulin: A preliminary report
38. A combined study from centres in England and Baltimore
39. Incidence of maternal Rh immunization by ABO compatible and incompatible pregnancies
40. Prevention of primary Rh immunization. First report of the Western Canadian Trial, 1966–1968
41. Regulation of the immune response. I. Reduction in ability of specific antibody to inhibit long-lasting IgG immunological priming after removal of the Fc-fragment
42. Mechanisms of Rh immune suppression by Rh immune globulin
43. Mechanisms of Rh prophylaxis: An experimental study on specificity of immunosuppression
44. Effect on primary Rh-immunization of delayed administration of anti-Rh
45. Rh sensitization after genetic amniocentesis
46. Rh isoimmunization related to amniocentesis
47. Studies on Rh prophylaxis: II. Rh immune prophylaxis after transfusions with Rh-positive blood
48. Studies on Rh prophylaxis: I. Relationship between doses of anti-Rh and size of antigenic stimulus
49. Detection and quantitation of fetal maternal hemorrhage utilizing an enzyme-linked antiglobulin test
50. 2 indicator erythrocytes
51. Pathogenesis of Rh immunization in primigravidas. Fetomaternal versus maternofetal bleeding
52. A case for the antenatal administration of anti-D immunoglobulin to primigravidae
53. Antenatal Rh prophylaxis: 28 weeks’ gestation service program
54. WinRho: Rh immune globulin prepared by ion exchange for intravenous use
55. Failures of intravenous Rh immune globulin prophylaxis: An analysis of the reasons for such failures
56. The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae
57. Sounding board. Rh immunoprophylaxis: Is antepartum therapy desirable?
58. Preventing rhesus isoimmunization: Antepartum Rh immune globulin prophylaxis versus a sensitive test for risk identification
59. Deaths from Rh hemolytic disease in England and Wales in 1984 and 1985
60. Efficacy of antenatal Rh prophylaxis
61. Antibody-mediated immune suppression to the Rh factor: Animal models suggesting mechanism of action
62. Failure to augment primary Rh immunization using a small dose of “passive” IgG anti Rh
63. Can primary Rh immunization be augmented by passively administered antibody?
64. The transplacental passage of maternal erythrocytes into the fetus
65. Maternal-fetal hemorrhage: Incidence and sensitization
66. Hydrops fetalis caused by massive maternofetal transplacental hemorrhage
67. Maternofetal transfusion during delivery and Rh sensitization of the newborn
68. The detection of anti-D in Rho(D)-negative infants born of Rho(D)-positive mothers
69. Matemofetal transfusion during delivery and sensitization of the newborn against Rhesus D-antigen
70. Reversal of Rh alloimmunization. Fact or Fancy?
71. Significance of Rh-sensitization during pregnancy: Its relation to a preventive programme
72. Suppression of early rhesus sensitization by passive anti-D immunoglobulin
73. Failure of passively administered anti-Rh to prevent secondary Rh immune responses
74. Controversies in Rh prophylaxis: Who needs Rh immune globulin and when should it be given?
75. Accident survenu apres injection de gamma-globulines anti-Rh du a la presence D/ anti-corps anti-yA
76. Prevention of Rh-immunization: Modified production of IgG anti-Rh for intravenous application by ion exchange chromatography (IEC)
77. Production of human monoclonal antibody to Rhesus D antigen
78. Further characterisation of a human monoclonal antibody to the Rhesus D antigen produced in vitro
79. Production of human monoclonal IgG antibodies against Rhesus (D) antigen
80. Production and characterization of human-human and human-mouse hybridomas secreting Rh(D)-specific monoclonal antibodies
81. Total prevention of Rh hemolytic disease Possible or Impossible?
82. The inheritance of the Rh blood groups: Frequencies in 1000 unrelated Caucasian families consisting of 2000 parents and 2806 children
83. Rh-isoimmunization